Dental Materials
Volume 22, Issue 1 , Pages 37-44 , January 2006

Roles of nitric oxide and prostacyclin in triethyleneglycol dimethacrylate (TEGDMA)-induced vasorelaxation

  • Worku Abebe

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +706 721 3181; fax: +706 721 6252.
    • ,
  • William F. Maddux

      Affiliations

    • Present address: William F. Maddux, Allen Dental Clinic, Bldg. 6037, Fort Sill, OK 73503, USA.

Received 13 July 2004 ,Revised 15 December 2004 ,Accepted 8 February 2005.

References 

  1. Peutzfeldt A. Resin composites in dentistry: the monomer system. Eur J Oral Sci. 1997;105:97–116
  2. Caughman WF, Caughman GB, Dominy WT, Schuster GS. Glass ionomer and composite resin cements: effects on oral cells. J Prosthet Dent. 1990;63:513–521
  3. Geurtsen W, Leyhausen G. Chemical-biological interactions of the resin monomer triethyleneglycol-dimethacrylate (TEGDMA). J Dent Res. 2001;80:2046–2050
  4. Lee SY, Huang HM, Lin CY, Shih YH. Leached components from dental composites in oral simulating fluids and the resultant composite strengths. J Oral Rehabil. 1998;25:575–588
  5. Lefebvr CA, Schuster GS, Rueggeberg FA, Tamareselvy K, Knoernschild KL. Responses of oral epithelial cell to dental components. J Biomater Sci Polym Edn. 1996;7:965–976
  6. Spahl W, Budzikiewicz H, Geurtsen W. Determination of leachable components from four commercial dental composites by gas and liquid chromatography/mass spectrometry. J Dent. 1998;26:137–145
  7. Ortengren U, Langer S, Goransson A, Lundgren T. Influence of pH and time on organic substance release from a model dental composite: a fluorescence spectrophotometry and gas chromatography/mass spectrometry analysis. Eur Oral Sci. 2004;112:530–537
  8. Geurtsen W. Substances released from dental composite resins and glass ionomer-cements. Eur J Oral Sci. 1998;106:687–695
  9. Gerzina TM, Hume WR. Diffusion of monomers from bonding resin-resin composite combinations through dentine in vitro. J Dent. 1996;24:125–128
  10. Walther UI, Siagian II, Walther SC, Reichl FX, Hickel R. Antioxidative vitamins decrease cytotoxicity of HEMA and TEGDMA in cultured cell lines. Arch Oral Bio. 2004;49:125–131
  11. Maddux WF, Abebe W, Schuster GS, Mozaffari M. Effects of dental resin components on vascular reactivity. J Biomed Mater Res. 2002;61:572–580
  12. Gornik HL, Creager MA. Arginine and endothelial and vascular health. J Nutr. 2004;134:2880S–2887S
  13. Wise H, Wong YH, Jones RL. Prostanoid signal integration and cross talk. Neurosignals. 2002;11:20–28
  14. Moncada S, vane JR. Arachidonic acid metabolites and the interactions between platelets and blood vessel wall. NEJM. 1997;300:1142–1147
  15. Abebe W, Cavallari N, Agrawal DK, Rowley J, Thorpe PE, Hunter WJ, et al. Functional and morphological assessment of rat aorta stored in University of Wisconsin and Eurocollins solutions. Transplantation. 1993;56:808–816
  16. Abebe W, Mozaffari M. Taurine depletion alters vascular reactivity in rats. Can J Physiol Pharmacol. 2003;81:903–909
  17. Ylikorkala O, Makila UM. Prostacyclin and thromboxane in gynecology and obstetrics. Am J Obst Gyn. 1985;152:318–329
  18. Tseng CHL, Fard MAT, Fung OH. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation. J Pharmacol Exp Ther. 2000;292:737–742
  19. Hourani SMO, Boon K, Fooks HM, Prentice D. Role of cyclic nucleotides in vasorelaxations of the rat thoracic aorta induced by adenosine analogues. Br J Pharmacol. 2001;133:833–840
  20. Ellis JL, Sham JS, Undem BJ. Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation. Hypertension. 1997;29:254–261
  21. Kageyams K, Furukawa K, Miki I, Teru K, Motomura S, Suda T. Vasodilative effects of urocortin II via protein kinase A and a mitogen-activating protein kinase in rat thoracic aorta. J Cardiovasc Pharmacol. 2003;42:561–565
  22. Abebe W, Mozaffari M. Effects of chronic taurine treatment on reactivity of the rat aorta. Amino Acids. 2000;19:615–623
  23. Guimaraes S, Moura D. Vascular adrenoceptors: an uptate. Pharmacol Rev. 2001;53:319–356
  24. Esler M, Kaye D, Lambert G, Esler D, Jennings G. Adrenergic nervous system in heart failure. Biochim Biophys Acta. 1988;944:273–278
  25. Stjarne L. Do sympathetic nerves release noradrenaline in ‘quanta’?. J Auton Nerv Syst. 2001;81:236–243
  26. Fleming I, Julou-Schaeffer G, Gray GA, Parratt JR, Stoclet JC. Evidence that an L-arginine/nitric oxide dependant elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin. Br J Pharmacol. 1991;103:1047–1052
  27. Olanrewaju A, Qin W, Feoktistov JLS, Mustafa SJ. Adenosine A2A and A2B receptors in cultured human and porcine coronary artery endothelial cells. Am J Physiol. 2000;279:H650–H656
  28. Pande G. The role of membrane lipids in regulation of integrin functions. Curr Opin Cell Biol. 2000;12:569–574
  29. Gilbert TM, Pashley DH, Anderson RW. Response of pulpal blood flow to intraarterial infusion of endothelin. J Endodont. 1992;18:228–231
  30. Yu CY, Boyd NM, Cringle SJ, Su EN, Alder VA, Yu DY. Acetylcholine-induced vasodilation of isolated pulpal arteriols. J Dent Res. 2001;80:1995–1999
  31. Tang T, Joyer WL. Differential role of endothelial function on vasodilator responses in series-arranged arteriols. Microcirc Res. 1992;44:61–72
  32. Bertuglia S, Colantuoni A, Intaglietta M. Capillary reperfusion after L-arginine, L-NMMA, and L-NNA treatment in cheek pouch microvasculature. Microcirc Res. 1995;50:162–174
  33. Abebe W, Pashley DH, Rueggeberg FA. Vasorelaxant effect of resin-based, single-bottle dentin bonding systems. J. Endodont 2005;31:194–197.
  34. Karlsson J, Wendling W, Chen D, Zelinsky J, Jeevanadam V, Hellman S, et al. Methylmethacrylate monomer produces direct relaxation of vascular smooth muscle in vitro. Acta Anaesthesiol Scand. 1995;39:685–689

PII: S0109-5641(05)00126-0

doi: 10.1016/j.dental.2005.02.008

Dental Materials
Volume 22, Issue 1 , Pages 37-44 , January 2006

Article Tools

* Image Usage & Resolution